Trial · NCT03296527
Results by group242
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 242
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | FE 000049 (Follitropin Delta) | Any preventive intervention | 1.2 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | GONAL-F (Follitropin Alfa) | Any preventive intervention | 3.5 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | FE 000049 (Follitropin Delta) | Early OHSS (any grade) and/or preventive interventions | 5.0 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | GONAL-F (Follitropin Alfa) | Early OHSS (any grade) and/or preventive interventions | 9.6 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | FE 000049 (Follitropin Delta) | Early OHSS (moderate/severe) and/or preventive interventions | 4.6 | percentage of participants | |
| Proportion of Subjects With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | GONAL-F (Follitropin Alfa) | Early OHSS (moderate/severe) and/or preventive interventions | 7.8 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | FE 000049 (Follitropin Delta) | Cycle cancellation due to poor response | 3.4 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | GONAL-F (Follitropin Alfa) | Cycle cancellation due to poor response | 0.8 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | FE 000049 (Follitropin Delta) | Cycle cancellation due to excessive response | 0 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | GONAL-F (Follitropin Alfa) | Cycle cancellation due to excessive response | 0 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | FE 000049 (Follitropin Delta) | Transfer cancellation due to excessive ovarian response/ OHSS risk | 5.2 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | GONAL-F (Follitropin Alfa) | Transfer cancellation due to excessive ovarian response/ OHSS risk | 12.4 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | FE 000049 (Follitropin Delta) | Cycle cancellation: poor/excessive response, or transfer cancellation excessive response/OHSS risk | 8.6 | percentage of participants | |
| Proportion of Subjects With Cycle Cancellation Due to Poor or Excessive Ovarian Response or Embryo Transfer Cancellation Due to Excessive Ovarian Response / OHSS Risk | GONAL-F (Follitropin Alfa) | Cycle cancellation: poor/excessive response, or transfer cancellation excessive response/OHSS risk | 13.1 | percentage of participants | |
| Number of Follicles on Stimulation Day 6 | FE 000049 (Follitropin Delta) | Follicles >= 10 mm | 5.4 | Standard Deviation 3.5 | number of follicles |
| Number of Follicles on Stimulation Day 6 | GONAL-F (Follitropin Alfa) | Follicles >= 10 mm | 6.4 | Standard Deviation 4.0 | number of follicles |
| Number of Follicles on Stimulation Day 6 | FE 000049 (Follitropin Delta) | Follicles >= 12 mm | 2.3 | Standard Deviation 2.2 | number of follicles |
| Number of Follicles on Stimulation Day 6 | GONAL-F (Follitropin Alfa) | Follicles >= 12 mm | 2.9 | Standard Deviation 2.5 | number of follicles |
| Number of Follicles on Stimulation Day 6 | FE 000049 (Follitropin Delta) | Follicles >= 15 mm | 0.3 | Standard Deviation 0.7 | number of follicles |
| Number of Follicles on Stimulation Day 6 | GONAL-F (Follitropin Alfa) | Follicles >= 15 mm | 0.3 | Standard Deviation 0.8 | number of follicles |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03296527/results?page=2